Coriolis scientist speaks at AATP Conference in Paris

2019/09/12

AATP Paris

Dr. Constanze Helbig will share insight into the orthogonal analysis of aggregates and particles in biopharmaceuticals.

We are proud that our research scientist Dr. Constanze Helbig represents Coriolis at the Advanced Analytical Technologies for Proteins (AATP) conference from 2.-3. October 2019. She will be available throughout the event for discussion and will talk about capabilities of analytical technologies in her presentation “Orthogonal analysis of aggregates and particles in biopharmaceutical products”.

The AATP event is a transdisciplinary two-day scientific conference that addresses protein characterization and allows experts to discuss challenges and unmet needs of protein analysis.

Click here to register for the event – We hope to meet you there!

Coriolis offers AUC under GMP

News

Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings

Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring.

Modeling the future of Lyophilization

News

Modelling The Future Of Lyophilization

Coriolis experts Andrea Arsiccio and Brecht Vanbillemont publish article on lyophilization modelling in "the Medicine Maker".

Donations 2023

News

Coriolis donates to aid organizations

Coriolis spreads the Christmas spirit and donates to organizations that help people in need, fight for a healthy nature, or improve our society as a whole

Tim Menzen

News

Tim Menzen honored by JPharmSci as Outstanding Early Career Scientist

The Editorial Staff and the American Pharmacists Association have been recognizing outstanding outstanding early career scientists for publishing their most original and significant scientific findings ...

Gideon Kersten Leiden University

News

Coriolis Pharma re-establishes Chair in Vaccine development at Leiden University

Leiden University re-appoints Prof. Dr. Gideon Kersten to the Chair in Vaccine development for a third 5-year term.

Coriolis News

News

Coriolis Pharma announces strategic growth partnership with KKR and Frontier Biosolutions

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint.

Johannes Clemens

News

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development. He will be responsible for expanding Coriolis’ worldwide activities and services, including client business and the establishment of new collaborative partnerships.

Continued Freeze Drying

News

Coriolis Pharma and RheaVita join forces in collaboration for continuous and controlled freeze-drying technology

Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.

Coriolis sponsors GFK sailing team

News

Coriolis sponsors GFK sailing team

Coriolis sponsors GFK sailing team at H-Boat World Cup race from August 1-4, 2023, on Lake Garda in Italy. We keep our fingers crossed.

Coriolis contributes to CNATM

News

Coriolis contributes to CNAT-M

Coriolis contributes to CNATM with drug product development expertise and formulation know-how to enable the transformation from innovative molecules towards drug products suitable for human application.